Ozagrel
From Self-sufficiency
File:Ozagrel.png | |
Systematic (IUPAC) name | |
---|---|
(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]acrylic acid | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 82571-53-7 |
ATC code | none |
PubChem | CID 5282440 |
Chemical data | |
Formula | C13H12N2O2 |
Molar mass | 228.24 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Ozagrel (INN) is an antiplatelet agent working as a thromboxane A2 synthesis inhibitor.[1]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Imidazoles
- 2Fix